Table 3.
Cost savings per negative-screened woman of universal PPD prevention relative to selective or indicated PPD prevention from societal and health system perspectives*
| (Prob[PPD] in ECAU minus prob[PPD] in ROSE) among negative risk screens | Provider Cost per ROSE Participant | ||||
|---|---|---|---|---|---|
| $50 (all low-cost group) | $100 | $150 | $225 | $300 (all individual) | |
| Universal, 0% | Societal: (78) Health: (3) |
Societal:(128) Health: (53) |
Societal:(178) Health: (103) |
Societal:(253) Health: (178) |
Societal:(328) Health: (253) |
| Universal, 1% | Societal: 242 Health: 168 |
Societal: 192 Health: 118 |
Societal: 142 Health: 68 |
Societal: 67 Health: (7) |
Societal: (8) Health: (82) |
| Universal, 3% | Societal: 882 Health: 510 |
Societal: 832 Health: 460 |
Societal: 782 Health: 410 |
Societal: 707 Health: 335 |
Societal: 632 Health: 260 |
| Universal, 10% | Societal: 3122 Health: 1707 |
Societal: 3072 Health: 1657 |
Societal: 3022 Health: 1607 |
Societal: 2947 Health: 1532 |
Societal: 2872 Health: 1457 |
*
Societal/health system costs for selective/indicated prevention per screened negative woman range from $33–60. We used the midpoint ($47) for illustrative purposes. Red #s are negative.